News Daily News MATRIX: No Hay Diferencias entre Bivalirudina y Heparina No Fraccionada en Pacientes SCA Con o Sin Elevación del Segmento ST Shelley Wood October 03, 2016
News Daily News Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI Michael O'Riordan August 24, 2016
News Daily News Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected? Yael L. Maxwell July 27, 2016
News Daily News Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests Yael L. Maxwell June 20, 2016
News Daily News A Closer Look at Bleeding Avoidance Strategies in PCI Reveals Little Impact on Outcomes Yael L. Maxwell April 25, 2016
News Daily News Un Análisis Certero de Estrategias para la Evitación de Hemorragias en PCI Revela Poco Impacto en los Resultados Yael L. Maxwell April 25, 2016
News Opinion Editor's Corner ACC 2016 Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016 Shelley Wood April 13, 2016
News Conference News ACC 2016 Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding Todd Neale April 06, 2016
News Daily News New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options Todd Neale March 01, 2016
News Daily News Nuevos Roles de las Clínicas Especializadas en Anticoagulación en una Era de Opciones Sin Warfarina Todd Neale March 01, 2016
News Industry News Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference February 22, 2016
News Daily News In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients Todd Neale January 25, 2016
News Daily News PCI for Cardiogenic Shock: Mortality Has Increased, but So Has Patient Risk Yael L. Maxwell January 20, 2016
News Daily News PCI para el Manejo del Shock Cardiogénico: La Mortalidad ha Aumentado Pareja al Riesgo de los Pacientes Yael L. Maxwell January 20, 2016
News Daily News Former FDA Staffer Says Missing Data Across Antithrombotic Trials Cast Doubt on Drug Effects Shelley Wood January 18, 2016
News Daily News Antiguo Miembro de la FDA Dice que los Datos que Faltan sobre Ensayos Antitrombóticos arrojan una Sombra sobre los Efectos del Fármaco Shelley Wood January 18, 2016
News Daily News Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond December 23, 2015